Pulmonary artery aneurysms in Behçet's syndrome: A review of the literature with emphasis on geographical differences

Basit Öğe Kaydı
dc.authorscopusid57214412177
dc.authorscopusid7004584825
dc.authorscopusid6603267445
dc.authorscopusid7102511786
dc.contributor.authorCelik S.
dc.contributor.authorYazici Y.
dc.contributor.authorSut N.
dc.contributor.authorYazici H.
dc.date.accessioned2024-06-12T10:29:21Z
dc.date.available2024-06-12T10:29:21Z
dc.date.issued2015
dc.description.abstractObjective. To investigate the frequency of Behçet's syndrome (BS) with pulmonary artery aneurysms (PAA) publications, the most lethal complication of BS, as reported from different countries and to provide a review of diagnostic techniques, treatment approaches and prognosis. Methods. Countries from each continent with a population of 4 million and over were chosen (n=128). A PubMed search for "BS, PAA and the country name" was conducted and 23 countries with BS and PAA were identified. The full texts of articles (n=91) were analysed for data including gender, age, accompanying vascular findings, diagnostic techniques, treatment modalities and mortality rates. Results. A total of 207 (183 males, 24 females) patients with BS and PAA were reported in 91 articles originating from 23 countries. As expected there was a significant correlation (r=0.88, p < 0.001) between the total number of articles about BS (n=4431) and those related to PAA and BS. In a simple linear regression analysis the number of BS and PAA articles from Japan was significantly below the identity line while in Turkey there was a propensity to publish more articles related to PAA than expected. One hundred and sixteen patients (56%) were treated with immunosuppressive therapy. Biologics were used only in 5 patients (2%). Of the 207 patients, 62 (30%) died. Conclusion. PAA is mostly reported as case reports from countries where BS is common. PAA might be uncommon in Japan. The prognosis of PAA could be getting better. © Clinical and Experimental Rheumatology 2015.en_US
dc.identifier.endpage59en_US
dc.identifier.issn0392-856X
dc.identifier.pmid26211653en_US
dc.identifier.scopus2-s2.0-84954582818en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage54en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/17716
dc.identifier.volume33en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherClinical and Experimental Rheumatology S.A.S.en_US
dc.relation.ispartofClinical and Experimental Rheumatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBehçet's Syndrome; Pulmonary Artery Aneurysmsen_US
dc.subjectBiological Product; Immunosuppressive Agent; Africa; Age; Artery Surgery; Article; Artificial Embolism; Asia; Behcet Disease; Diagnostic Procedure; Europe; Gender; Geography; Human; Immunosuppressive Treatment; Japan; Medical Literature; Mortality; Mortality Rate; North America; Pacific Islands; Priority Journal; Prognosis; Publication; Pulmonary Artery Aneurysm; South America; Turkey (Republic); Adolescent; Adult; Aneurysm; Behcet Syndrome; Female; Male; Middle Aged; Pulmonary Artery; Risk Factor; Young Adult; Adolescent; Adult; Aneurysm; Behcet Syndrome; Female; Humans; Male; Middle Aged; Prognosis; Pulmonary Artery; Risk Factors; Young Adulten_US
dc.titlePulmonary artery aneurysms in Behçet's syndrome: A review of the literature with emphasis on geographical differencesen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu